Immunoassay Instruments Market (Product Chemiluminescence (CLI), Immunofluorescence (IFA) & Radioimmunoassay (RIA) Analyzers, Enzyme Linked Fluorescence (ELFA) & Multiplexed Assay Systems, Enzyme Immunoassay Instruments Application Oncology, Endocrinology, Infectious Diseases, Therapeutic Drug Monitoring, Cardiology, Autoimmune Disorders & Drugs of Abuse) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020
Immunoassay Instruments Market, by Product Type
- Chemiluminescence (CLI) Analyzers
- Immuno Fluorescence (IFA) Analyzers
- Enzyme Immunoassay Instruments
- Radioimmunoassay Analyzers
- Enzyme Linked Fluorescent Systems
- Multiplexed Assay Systems
Immunoassay Instruments Market, by Application
- Infectious Diseases
- Therapeutic Drug Monitoring
- Autoimmune Diseases
- Drugs of Abuse
Immunoassay Instruments Market, by Geography
- North America
- Rest of the World (RoW)
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Latin America
- The Middle East and Africa
The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.
Below is a snapshot of these quadrants.
1. Customer Experience Map
The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.
2. Insights and Tools
The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.
3. Actionable Results
The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.
4. Strategic Frameworks
The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
1. What can be the best investment choices for venturing into new product and service lines?
2. What value propositions should businesses aim at while making new research and development funding?
3. Which regulations will be most helpful for stakeholders to boost their supply chain network?
4. Which regions might see the demand maturing in certain segments in near future?
5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
7. Which government regulations might challenge the status of key regional markets?
8. How will the emerging political and economic scenario affect opportunities in key growth areas?
9. What are some of the value-grab opportunities in various segments?
10. What will be the barrier to entry for new players in the market?
With a robust experience in creating exceptional market reports, Transparency Market Research has emerged as one of the trusted market research companies among a large number of stakeholders and CXOs. Every report at Transparency Market Research goes through rigorous research activity in every aspect. The researchers at TMR keep a close watch on the market and extract beneficial growth-boosting points. These points help the stakeholders to strategize their business plans accordingly.
TMR researchers conduct exhaustive qualitative and quantitative research. This research involves taking inputs from the experts in the market, focused attention on recent developments, and others. This method of research makes TMR stand out from other market research firms.
Here's how Transparency Market Research helps the stakeholders and CXOs through the reports:
Inculcation and Evaluation of Strategic Collaborations: The TMR researchers analyze recent strategic activities like mergers, acquisitions, partnerships, collaborations, and joint ventures. All the information is compiled and included in the report.
Perfect Market Size Estimations: The report analyzes the demographics, growth potential, and capability of the market through the forecast period. This factor leads to the estimation of the market size and also provides an outline about how the market will retrieve growth during the assessment period.
Investment Research: The report focuses on the ongoing and upcoming investment opportunities across a particular market. These developments make the stakeholders aware of the current investment scenario across the market.
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.
List of Figures
FIG. 1 Immunoassay Instruments Market Segmentation
FIG. 2 Global Immunoassay Instruments Market, by Applications, 2013 (USD Billion)
FIG. 3 Global Immunoassay Instruments Market, by Products, 2013 (USD Billion)
FIG. 4 Comparative Analysis: Global Electrodes for Medical Devices Market, by Geography, 2013 & 2020 (Value %)
FIG. 5 Immunoassay Development, Optimization and Validation Process
FIG. 6 Biomarker Discovery Process
FIG. 7 Rate of HIV Infections by World Regions, (2001 – 2012)
FIG. 8 Global Immunoassay Instruments Market Value Chain Analysis
FIG. 9 Porter’s Five Forces Analysis: Global Immunoassay Instruments Market
FIG. 10 Market Attractiveness Analysis: Global Immunoassay Instruments Market, by Geography, 2013
FIG. 11 Comparative Analysis: Global Immunoassay Instruments Market, by End Users, 2013 & 2020 (Value %)
FIG. 12 Immunoassay Instruments: Global Market Share by Key Players, 2013 (Value %)
FIG. 13 Comparative Analysis: Global Immunoassay Instruments Market, by Products, 2013 & 2020 (Value %)
FIG. 14 Global Chemiluminescence (CLI) Analyzers Market Revenue, 2012 – 2020 (USD Billion)
FIG. 15 Global Immunofluorescence Analyzers Market Revenue, 2012 – 2020 (USD Billion)
FIG. 16 Global Enzyme Immunoassay (EIA) Instruments Market Revenue, 2012 - 2020 (USD Billion)
FIG. 17 Global Radioimmunoassay (RIA) Instruments Market Revenue, 2012 – 2020 (USD Billion)
FIG. 18 Global ELFA Instruments Market Revenue, 2012 – 2020 (USD Billion)
FIG. 19 Global Multiplexed Assay Systems Market Revenue, 2012 – 2020 (USD Billion)
FIG. 20 Comparative Analysis: Global Immunoassay Instruments Market, by Application, 2013 & 2020 (Value %)
FIG. 21 Global Endocrinology Application Market Revenue, 2012 – 2020 (USD Billion)
FIG. 22 Global Infectious Disease Testing Application Market Revenue, 2012 – 2020 (USD Billion)
FIG. 23 Global Oncology Application Market Revenue, 2012 – 2020 (USD Billion)
FIG. 24 Global Cardiology Application Market Revenue, 2012 – 2020 (USD Billion)
FIG. 25 Global Therapeutic Drug Monitoring Application Market Revenue, 2012 – 2020 (USD Billion)
FIG. 26 Global Autoimmune Diseases Testing Application Market Revenue, 2012 – 2020 (USD Billion)
FIG. 27 Global Drug Abuse Testing Application Market Revenue, 2012 – 2020 (USD Billion)
FIG. 28 North America Immunoassay Instruments Market Revenue, 2012 – 2020 (USD Billion)
FIG. 29 Europe Immunoassay Instruments Market Revenue, 2012 – 2020 (USD Billion)
FIG. 30 Asia-Pacific Immunoassay Instruments Market Revenue, 2012 – 2020 (USD Billion)
FIG. 31 RoW Immunoassay Instruments Market Revenue, 2012 – 2020 (USD Billion)
FIG. 32 Abbott Laboratories, Inc.: Annual Revenue, 2011 – 2013 (USD Million)
FIG. 33 bioMerieux, Inc.: Annual Revenue, 2011 – 2013 (USD Million)
FIG. 34 DiaSorin, Annual Revenue: 2011 – 2013 (USD Million)
FIG. 35 F. Hoffman-La Roche, Ltd.: Annual Revenue (Group Sales), 2011 – 2013 (USD Million)
FIG. 36 Merck Millipore, Annual Revenue, 2010 – 2012 (USD million)
FIG. 37 Ortho Clinical Diagnostics, Annual Revenue: 2011 – 2013 (USD Million)
FIG. 38 Siemens Healthcare, Annual Revenue (Group Revenue): 2011– 2013 (USD Million)
FIG. 39 Sysmex Corporation, Annual Revenue, 2011 – 2013 (USD Million)
FIG. 40 Thermo Fisher Scientific, Annual Revenue: 2011 – 2013 (USD million)